Cargando…
Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side
Recent clinical trials using patient’s own corrected hematopoietic stem cells (HSCs), such as for primary immunodeficiencies (Adenosine deaminase (ADA) deficiency, X-linked Severe Combined Immunodeficiency (SCID), X-linked chronic granulomatous disease (CGD), Wiskott–Aldrich Syndrome (WAS)), have yi...
Autores principales: | Garcia-Perez, Laura, Ordas, Anita, Canté-Barrett, Kirsten, Meij, Pauline, Pike-Overzet, Karin, Lankester, Arjan, Staal, Frank J. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357087/ https://www.ncbi.nlm.nih.gov/pubmed/32545727 http://dx.doi.org/10.3390/pharmaceutics12060549 |
Ejemplares similares
-
Genomic Engineering in Human Hematopoietic Stem Cells: Hype or Hope?
por: Klaver-Flores, Stefanie, et al.
Publicado: (2021) -
Inflammation and Wnt Signaling: Target for Immunomodulatory Therapy?
por: Jridi, Imen, et al.
Publicado: (2021) -
Stem Cell-Based Disease Models for Inborn Errors of Immunity
por: Zbinden, Aline, et al.
Publicado: (2021) -
Combining Mobilizing Agents with Busulfan to Reduce Chemotherapy-Based Conditioning for Hematopoietic Stem Cell Transplantation
por: Garcia-Perez, Laura, et al.
Publicado: (2021) -
Multi-omic analyses in immune cell development with lessons learned from T cell development
por: Cordes, Martijn, et al.
Publicado: (2023)